By Joseph Keenan – Fierce Pharma –
Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process.
The two companies will integrate Multiply Lab’s robotic technology and Thermo Fisher’s cell therapy instruments to “fully” automate production of the advanced therapies, according to a Feb. 12 press release.
Financial terms of the partnership weren’t disclosed. Thermo Fisher, along with Charles River Labs, first signed on with Multiply Labs in 2022 to automate cell therapy production.